Home
4basebio PLC

4basebio PLC Market Share Analysis for May 2026

Description4basebio is a world-leading expert in cutting edge, innovative technologies and services for life sciences and diagnostics. Summarized from the website

Industry: N/A

Domain4basebio.com

Year Founded2008

Employees51 - 200

Annual Revenue< $1M

4basebio PLC

4basebio PLC (including company regionals)

4basebio.com

See more website traffic and engagement information

Total visits to 4basebio PLC's top domains

Understand 4basebio PLC market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

4basebio.com4.8K

See more with Sales Intelligence

Avg. visit duration in 4basebio PLC's top domains

Analyze 4basebio PLC engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

4basebio.com00:00:03

See more with Sales Intelligence

Avg. pageviews on 4basebio PLC's top domains

See how 4basebio PLC keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

4basebio.com1.54

See more with Sales Intelligence

4basebio PLC top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by 4basebio PLC

These are the website technologies, by industry, used by 4basebio PLC top domains

Payment & Currencies (7)

Cart Functionality

Advertising (5)

DoubleClick

Conversion & Analytics (4)

Google Analytics

Widget (4)

reCAPTCHA

More Technologies

11

See all

News & Signals from 4basebio PLC

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBaseBio hired Jeff Coller as Strategic Advisory Board on Jun 15th '26.4basebio appoints Dr. Jeff Coller to Strategic Advisory Board.

NewsBaseBio launches high-capacity single-stranded DNA product line.4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the commercial launch of its high-capacity single-stranded DNA (ssDNA) product line to accelerate the development of safer, more precise genetic therapies by enabling targeted gene editing, advanced cell engineering, and innovative nucleic acid-based medicines.